Prostate Cancer Horizons in the Development of Novel Anti-Cancer Strategies

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 1, Iss. 1, 2001-05 ,pp. : 47-70

Bentham Science Publishers

Access to resources Recommend Favorite

Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Zhou Shufeng   Kestell Philip   Tingle Malcolm   Paxton James  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 126-132

Springer Publishing Company

Access to resources Recommend Favorite

A novel anticancer effect of resveratrol: reversal of epithelialmesenchymal transition in prostate cancer cells

By                

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1717-1724

Spandidos Publications

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 6, 2006-01 ,pp. : 513-523

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer

By Turner P.   Houghton Janet   Petak Istvan   Tillman David   Douglas Leslie   Schwartzberg Lee   Billups Catherine   Panetta John   Stewart Clinton  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 253-260

Springer Publishing Company

Access to resources Recommend Favorite